Morning Market Gainers
ImmuCell Corporation (NASDAQ: ICCC) shares jumped 27.04 percent to $7.18 after the company reported results for the first quarter. The company reported quarterly net income of $479,000, versus a net loss of $13,000.
Williams Partners LP (NYSE: WPZ) shares rose 23.52 percent to $58.55 after Williams Companies Inc announced a deal to purchase all public equity of Williams Partners LP.
PDI, Inc. (NASDAQ: PDII) rose 23.62 percent to $1.57. PDI reported Q1 loss of $0.25 per share on sales of $38.319 million.
Rentrak Corporation (NASDAQ: RENT) shares jumped 14.99 percent to $58.77. Rentrak reported Q4 sales of $28.5 million.
TubeMogul Inc (NASDAQ: TUBE) gained 12.37 percent to $17.34 after the company posted first quarter earnings and raised its guidance. TubeMogul reported a Q1 loss of $0.24 per share on revenue of $30.3 million.
Alon Blue Square Israel Ltd (NYSE: BSI) climbed 10.83 percent to $3.07 after the company announced the resignation of Mega Retail's Chief Executive Officer.
Pain Therapeutics, Inc. (NASDAQ: PTIE) shares rose 7.77 percent to $2.82 after jumping 35.05 percent on Tuesday.
Hortonworks Inc (NASDAQ: HDP) shares jumped 6.88 percent to $23.29 after the company reported a narrower-than-expected loss for the first quarter.
Williams Companies Inc (NYSE: WMB) shares rose 6.81 percent to $53.51 after the company announced a deal to purchase all public equity of Williams Partners LP and lifted its Q3 dividend from $0.58 to $0.64 per share.
Pall Corporation (NYSE: PLL) shares surged 4.96 percent to $124.50 after the company agreed to be acquired by Danaher Corporation for $127.20 per share in cash.
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) shares climbed 4.55 percent to $129.72 on news that a regulatory advisory committee recommended approval of its cystic fibrosis treatment called Orkambi. An FDA decision is expected by July 5.
Danaher Corporation (NYSE: DHR) shares gained 3.07 percent to $88.64 after the company announced its plans to buy Pall Corp for $13.8 billion.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.